AdipoGen
Private Company
Total funding raised: $7M
Overview
AdipoGen is a privately-held, revenue-generating life sciences supplier providing critical research reagents and diagnostic tools to the global scientific community. The company leverages a multi-brand distribution and development model, offering products under its own AdipoGen Life Sciences label as well as from specialized partner brands like Ancell, BellBrook, and RevMAb. Its strategic focus on high-growth research fields like immuno-oncology, metabolism, and innate immunity positions it within the expansive and stable research tools market. While not a therapeutic developer, AdipoGen's commercial success is tied to enabling fundamental and translational research worldwide.
Technology Platform
Integrated distributor and developer of life science research reagents, including proprietary and multi-brand antibodies, proteins, assay kits, and small molecules, with a focus on validation and niche research areas like inflammasome biology and immunometabolism.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
AdipoGen competes in a crowded market dominated by giants like Thermo Fisher, Abcam, and Bio-Techne. Its strategy is to compete not on scale but on deep specialization in niche research areas, high-quality validated products, and a curated multi-brand portfolio that offers unique reagents not available from the broad-line majors.